Literature DB >> 10737926

Structure and dynamics of the pore-lining helix of the nicotinic receptor: MD simulations in water, lipid bilayers, and transbilayer bundles.

R J Law1, L R Forrest, K M Ranatunga, P La Rocca, D P Tieleman, M S Sansom.   

Abstract

Multiple nanosecond duration molecular dynamics simulations on the pore-lining M2 helix of the nicotinic acetylcholine receptor reveal how its structure and dynamics change as a function of environment. In water, the M2 helix partially unfolds to form a molecular hinge in the vicinity of a central Leu residue that has been implicated in the mechanism of ion channel gating. In a phospholipid bilayer, either as a single transmembrane helix, or as part of a pentameric helix bundle, the M2 helix shows less flexibility, but still exhibits a kink in the vicinity of the central Leu. The single M2 helix tilts relative to the bilayer normal by 12 degrees, in agreement with recent solid state NMR data (Opella et al., Nat Struct Biol 6:374-379, 1999). The pentameric helix bundle, a model for the pore domain of the nicotinic receptor and for channels formed by M2 peptides in a bilayer, is remarkably stable over a 2-ns MD simulation in a bilayer, provided one adjusts the pK(A)s of ionizable residues to their calculated values (when taking their environment into account) before starting the simulation. The resultant transbilayer pore shows fluctuations at either mouth which transiently close the channel. Proteins 2000;39:47-55. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737926     DOI: 10.1002/(sici)1097-0134(20000401)39:1<47::aid-prot5>3.0.co;2-a

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  15 in total

1.  Molecular dynamics simulations of wild-type and mutant forms of the Mycobacterium tuberculosis MscL channel.

Authors:  D E Elmore; D A Dougherty
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

2.  Interactions of the designed antimicrobial peptide MB21 and truncated dermaseptin S3 with lipid bilayers: molecular-dynamics simulations.

Authors:  Craig M Shepherd; Hans J Vogel; D Peter Tieleman
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  Interactions of hydrophobic peptides with lipid bilayers: Monte Carlo simulations with M2delta.

Authors:  Amit Kessel; Dalit Shental-Bechor; Turkan Haliloglu; Nir Ben-Tal
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

4.  Interactions of the M2delta segment of the acetylcholine receptor with lipid bilayers: a continuum-solvent model study.

Authors:  Amit Kessel; Turkan Haliloglu; Nir Ben-Tal
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

5.  Molecular dynamics simulations of the E1/E2 transmembrane domain of the Semliki Forest virus.

Authors:  Ana Caballero-Herrera; Lennart Nilsson
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

6.  Dynamics of the acetylcholine receptor pore at the gating transition state.

Authors:  Ananya Mitra; Gisela D Cymes; Anthony Auerbach
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

7.  Conformation and environment of channel-forming peptides: a simulation study.

Authors:  Jennifer M Johnston; Gabriel A Cook; John M Tomich; Mark S P Sansom
Journal:  Biophys J       Date:  2005-12-30       Impact factor: 4.033

8.  Molecular dynamics simulations of model trans-membrane peptides in lipid bilayers: a systematic investigation of hydrophobic mismatch.

Authors:  Senthil K Kandasamy; Ronald G Larson
Journal:  Biophys J       Date:  2006-01-20       Impact factor: 4.033

9.  Analysis and evaluation of channel models: simulations of alamethicin.

Authors:  D Peter Tieleman; Berk Hess; Mark S P Sansom
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

10.  Homology modelling and molecular dynamics simulations: comparative studies of human aquaporin-1.

Authors:  Richard J Law; Mark S P Sansom
Journal:  Eur Biophys J       Date:  2004-04-08       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.